Dendritic PARACEST contrast agents for magnetic resonance imaging

Contrast Media and Molecular Imaging

Volumn 2, Issue 5, 2007, Pages 229-239

  Pikkemaat, J A ^a   Wegh, R T ^a   Lamerichs, R ^a   van de Molengraaf, R A ^a   Langereis, S ^a   Burdinski, D ^a   Raymond, A Y F ^a,b   Janssen, H M ^c   de Waal, B F M ^b   Willard, N P ^a   Meijer, E W ^b   Grull H ^a  

^a PHILIPS RESEARCH LABORATORIES   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c SyMO Chem   (Netherlands)

Author keywords

DOTAM; Magnetic resonance imaging (MRI); Molecular imaging; PARACEST contrast agents; pH mapping; Poly(propylene imine) dendrimers; Ytterbium

Indexed keywords

1 (5 BENZYLOXYCARBONYLMETHYL) 4,7,10 (CARBAMOYLMETHYL) 1,4,7,10 TETRAAZACYCLODODECANE; 1 (BENZYLOXYCARBONYLMETHYL) 4,7,10 TRIS(TERT BUTYLOXYCARBONYL) 1,4,7,10 TETRAAZACYCLODODECANE; 1,4,7 TETRAKIS(CARBAMOYLMETHYL) 1,4,7,10 TETRAAZACYCLODODECANE TERMINATED POLY(PROPYLENE IMINE)DENDRIMER; 1,4,7 TETRAKIS(CARBAMOYLMETHYL) 1,4,7,10 TETRAAZACYCLODODECANE TERMINATED POLY(PROPYLENE IMINE)DENDRIMER YTTERBIUM; 1,4,7 TETRAKIS(CARBAMOYLMETHYL) 1,4,7,10 TETRAAZACYCLODODECANE YTTERBIUM; 1,4,7 TRIS(TERT BUTYLOXYCARBONYL) 1,4,7,10 TETRAAZACYCLODODECANE; 4,7,10 TRIS(CARBAMOYLMETHYL) 1,4,7,10 TETRAAZACYCLODODECANE 1 YL ACETIC ACID; AMIDE; CONTRAST MEDIUM; DENDRIMER; DIAGNOSTIC AGENT; PROTON; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

CONTRAST MEDIA; DENDRIMERS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; ORGANOMETALLIC COMPOUNDS; POLYPROPYLENES;

EID: 38649103503     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.149     Document Type: Article

References (50)

1. Merbach AE, Tóth E. The chemistry of contrast agents in medical magnetic resonance imaging. John Wiley & Sons: New York, 2001.
2. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev. 1999; 99: 2293-2352.
3. Aime S, Botta M, Crich SG, Giovenzana G, Palnidsano G, Sisti M. A macromolecular Gd(III) complex as pH-responsive relaxometric probe for MRI applications. Chem. Commun. 1999; 1577-1578.
4. Zhang SR, Wu KC, Sherry AD. Gd3+ complexes with slowly exchanging bound-water molecules may offer advantages in the design of responsive MR agents. Invest. Radiol. 2001; 36: 82-86.
5. Hovland R, Glogard C, Aasen AJ, Klaveness J. Gadolinium DO3A derivatives mimicking phospholipids; preparation and in vitro evaluation as pH responsive MRI contrast agents. Perkin Trans. 2001; 2: 929-933.
6. Raghunand N, Zhang SR, Sherry AD, Gillies RJ. In vivo magnetic resonance imaging of tissue pH using a novel pH-sensitive contrast agent, GdDOTA-4AmP. Acad. Radiol. 2002; 9: S481-S483.
7. Laus S, Sour A, Ruloff R, Toth E, Merbach AE. Rotational dynamics account for pH-dependent relaxivities of PAMAM dendrimeric, Gd-based potential MRI contrast agents. Chem. Eur J. 2005; 11: 3064-3076.
8. Zhang SR, Wu KC, Sherry AD. A novel pH-sensitive MRI contrast agent. Angew. Chem. Int. Ed. 1999; 38: 3192-3194.
9. Vaupel P, Kallinowski F, Okunieff P. Blood-Flow, Oxygen and Nutrient Supply, and Metabolic Microenvironment of Human-Tumors - A Review. Cancer Res. 1989; 49: 6449-6465.
10. Aime S, Carrera C, Castelli DD, Crich SG, Terreno E. Tunable imaging of cells labeled with MRI-PARACEST agents. Angew. Chem. Int. Ed. 2005; 44: 1813-1915.
11. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219 316-333.
12. Lee AS, Weissleder R, Brady TJ, Wittenberg J. Lymph-Nodes - Microstructural Anatomy at MR Imaging. Radiology 1991; 178: 519-522.
13. Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: Phase III safety and efficacy study. Radiology 2003; 228: 777-788.
14. Torabi M, Aquino SL, Harisinghani MG. Current concepts in lymph node imaging. J. Nucl. Med. 2004; 45: 1509-1518.
15. Aime S, Delli Castelli D, Terreno E. Novel pH-reporter MRI contrast agents. Angew. Chem. Int. Ed. 2002; 41: 4334-4336.
16. Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J. Magn. Reson. 2000; 143: 79-87.
17. Forsen S, Hoffman RA. Study of Moderately Rapid Chemical Exchange Reactions by Means of Nuclear Magnetic Double Resonance. J. Chem. Phys. 1963; 39: 2892-2901.
18. Forsen S, Hoffman RA. Exchange Rates by Nuclear Magnetic Multiple Resonance. 3. Exchange Reactions in Systems with Several Non-Equivalent Sites. J. Chem. Phys. 1964; 40: 1189-1196.
19. Ward KM, Balaban RS. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn. Reson. Med. 2000; 44: 799-802.
20. Zhang SR, Michaudet L, Burgess S, Sherry AD. The amide protons of an ytterbium(III) dota tetraamide complex act as efficient antennae for transfer of magnetization to bulk water. Angew. Chem. Int. Ed. 2002; 41: 1919-1921.
21. Aime S, Barge A, Castelli DD, Fedeli F, Mortillaro, A, Nielsen FU, Terreno E. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn. Reson. Med. 2002; 47: 639-648.
22. Zhang SR, Winter P, Wu KC, Sherry AD. A novel europium(III)-based MRI contrast agent. J. Am. Chem. Soc. 2001; 123: 1517-1518.
23. Zhang SR, Merritt M, Woessner DE, Lenkinski RE, Sherry AD. PARACEST agents: Modulating MRI contrast via water proton exchange. Acc. Chem. Res. 2003; 36: 783-790.
24. 1, agents. Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 8443-8448.
25. Goffeney N, Bulte JWM, Duyn J, Bryant LH, van Zijl PCM. Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. J. Am. Chem. Soc. 2001; 123: 8628-8629.
26. Sun PZ, Zhou JY, Sun WY, Huang J, van Zijl PCM. Suppression of lipid artifacts in amide proton transfer imaging. Magn. Reson. Med. 2005; 54: 222-225.
27. Zhou JY, van Zijl PCM. Chemical exchange saturation transfer imaging and spectroscopy. Progr Nucl. Magn. Reson. Spectr. 2006; 48: 109-136.
28. Aime S, Delli Castelli D, Terreno E. Supramolecular adducts between poly-L-arginine and [Tm(III)dotp]: A route to sensitivity-enhanced magnetic resonance imaging-chemical exchange saturation transfer agents. Angew. Chem. Int. Ed. 2003; 42: 4527-4529.
29. Zhang S, Michadet L, Sherry AD. PARACEST agents based upon DOTA-like conjugates with poly-L-lysine. Proc. Int. Magn. Reson. Med. 2005; 13: 2708.
30. Terreno E, Cabella C, Carrera C, Castelli DD, Mazzon R, Rollet S, Stancanello J, Visigalli M, Aime S. From spherical to osmotically shrunken paramagnetic liposomes: An improved generation of LIPOCEST MRI agents with highly shifted water protons. Angew. Chem. Int. Ed. 2007; 46: 966-9968.
31. Aime S, Castelli DD, Terreno E. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. Angew. Chem. Int. Ed. 2005; 44: 5513-5515.
32. Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents. Magn. Reson. Med. 1994; 31 1-8.
33. Kobayashi H, Kawarnoto S, Jo S-K, Bryant HL Jr, Brechbiel MW, Star RA, Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjug. Chem. 2003; 14: 388-394.
34. Langereis S, de Lussanet QG, van Genderen MHP, Backes WH, Meijer EW Multivalent contrast agents based on gadolinium-diethylenetriaminepentaacetic acid-terminated poly(propylene imine) dendrimers for magnetic resonance imaging. Macromolecules 2004; 37: 3084-3091.
35. Langereis S, de Lussanet QG, van Genderen MHP, Meijer EW, Beets-Tan RGH, Griffloen AW, van Engelshoven JMA, Backes WH. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging. NMR Biomed. 2006; 19: 133-141.
36. de Lussanet QG, Langereis S, Beets-Tan RGH, van Genderen MHP, Griffioen AW, van Engelshoven JMA, Backes WH. Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice. Radiology 2005; 235: 65-72.
37. Koper GJM, van Genderen MHP, Elissen-Roman C, Baars MWPL, Meijer EW, Borkovec M. Protonation Mechanism of Poly(propylene imine) Dendrimers and Some Associated Oligo Amines. J. Am. Chem. Soc. 1997; 119 6512-6521.
38. McMahon MT, Gilad AA, Zhou J, Sun PZ, Bulte JWM, van Zijl PCM. Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effects on the magnetic resonance imaging signal (QUEST and QUESP): PH calibration for poly-L-lysine and a starburst dendrimer. Magn. Reson. Med. 2006; 55: 836-847.
39. Liepinsh E, Otting G. Proton exchange rates from amino acid side chains - Implications for image contrast. Magn. Reson. Med. 1996; 35 30-42.
40. Englander SW, Downer NW, Teitelbaum H. Hydrogen-Exchange. Annu. Rev. Biochem. 1972; 41: 903-924.
41. Constable EC. Metals and Ligand Reactivity: An Introduction to the Organic Chemistry of Metal Complexes. VCH Weinheim: 1995.
42. Connelly GP, Bai YW, Jeng MF, Englander SW. Isotope Effects in Peptide Group Hydrogen-Exchange. Proteins: Structure Funct. Genet. 1993; 17: 87-92.
43. Gillies RJ, Raghunand N, Garcia-Martin ML, Gatenby RA. pH imaging. IEEE Engineering in Medicine and Biology Magazine 2004; 23: 57-64.
44. Terreno E, Castelli DD, Cravotto G, Milone L, Aime S. Ln(III)-DOTAMGly complexes: A versatile series to assess the determinants of the efficacy of paramagnetic chemical exchange saturation transfer agents for magnetic resonance imaging applications. Invest. Radiol. 2004; 39: 235-243.
45. Garcia-Martin ML, Martinez GV, Raghunand N, Sherry AD, Zhang SR, Gillies RJ. High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Magn. Reson. Med. 2006; 55: 309-315.
46. Maliakal AJ, Turro NJ, Bosman AW, Cornel J, Meijer EW. Relaxivity Studies on Dinitroxide and Polynitroxyl Functionalized Dendrimers: Effect of Electron Exchange and Structure on Paramagnetic Relaxation Enhancement. J. Phys. Chem. A. 2003; 107: 8467-8475.
47. Pittelkow M, Lewinsky R, Christensen JB. Selective synthesis of carbamate protected polyamines using alkyl phenyl carbonates. Synthesis 2002; 2195-2202.
48. Details concerning the SAR limits can be found on the following FDA website http://www.fda.gov/cdrh/ode/primerf6.html (last accessed in July 2007).
49. Kimura E, Aoki S, Koike T, Shiro M. A Tris(zinc-1,4,7,10-tetraazacyclododecane) Complex as a New Receptor for Phosphate Dianions in Aqueous Solution. J. Am. Chem. Soc. 1997; 119: 3068-3076.
50. 3+. J. Am. Chem. Soc. 2001; 123: 1123-1132.